These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25157527)

  • 1. Canadian Association of Gastroenterology position statement regarding the use of thiopurines for the treatment of inflammatory bowel disease.
    Marshall JK; Otley AR; Afif W; Bernstein CN; Hookey L; Leontiadis G; Panaccione R; Bressler B;
    Can J Gastroenterol Hepatol; 2014; 28(7):371-2. PubMed ID: 25157527
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatosplenic αβ T-cell lymphoma associated with azathioprine therapy.
    Rashidi A; Lee ME; Fisher SI
    Int J Hematol; 2012 May; 95(5):592-4. PubMed ID: 22527855
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequency of use and standards of care for the use of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease: a systematic review of the literature and a survey of Canadian gastroenterologists.
    Wallace TM; Veldhuyzen van Zanten SJ
    Can J Gastroenterol; 2001 Jan; 15(1):21-8. PubMed ID: 11173323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Cases of Hepatosplenic T-Cell Lymphoma in Adolescents Treated for Autoimmune Hepatitis.
    Brinkert F; Arrenberg P; Krech T; Grabhorn E; Lohse A; Schramm C
    Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27516526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant.
    Bašić Kinda S; Duraković N; Dotlić S; Serventi Seiwerth R; Davidović Mrsić S; Dubravčić K; Aurer I
    Leuk Lymphoma; 2013 Jun; 54(6):1334-5. PubMed ID: 23083012
    [No Abstract]   [Full Text] [Related]  

  • 6. Crohn's disease, hepatosplenic T-cell lymphoma and no biological therapy: are we barking up the wrong tree?
    Moran G; Dillon J; Green J
    Inflamm Bowel Dis; 2009 Sep; 15(9):1281-2. PubMed ID: 19067412
    [No Abstract]   [Full Text] [Related]  

  • 7. Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits?
    Su CG; Stein RB; Lewis JD; Lichtenstein GR
    Dig Liver Dis; 2000; 32(6):518-31. PubMed ID: 11057928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of 6-mercaptopurine/azathioprine in patients with inflammatory bowel disease.
    Marion JF
    Inflamm Bowel Dis; 1998 May; 4(2):116-7. PubMed ID: 9687219
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatosplenic T-cell lymphoma and inflammatory bowel disease.
    Thai A; Prindiville T
    J Crohns Colitis; 2010 Nov; 4(5):511-22. PubMed ID: 21122554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease.
    Mackey AC; Green L; Liang LC; Dinndorf P; Avigan M
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):265-7. PubMed ID: 17255842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in factor V activity: a new adverse effect of purine analogs in inflammatory bowel diseases?
    Poupeney S; Dray X; Reignier S; Vahedi K; Alhenc M; Belluci S; Marteau P
    Inflamm Bowel Dis; 2008 Jul; 14(7):1024-5. PubMed ID: 18286642
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply: Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
    Coelho T; Cheng G; Vazquez Lopez F; Ashton JJ; Beattie RM; Ennis S
    Inflamm Bowel Dis; 2024 Oct; 30(10):1928-1930. PubMed ID: 39011772
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab use and hepatosplenic T cell lymphoma: questions to be asked and lessons learned.
    Rosh JR; Oliva-Hemker M
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):165-7. PubMed ID: 17255825
    [No Abstract]   [Full Text] [Related]  

  • 15. Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.
    Gómez-García M; Cabello-Tapia MJ; Sánchez-Capilla AD; De Teresa-Galván J; Redondo-Cerezo E
    World J Gastroenterol; 2013 Aug; 19(30):4877-86. PubMed ID: 23946592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of thiopurines in the treatment of inflammatory bowel disease.
    de Jong DJ; Derijks LJ; Naber AH; Hooymans PM; Mulder CJ
    Scand J Gastroenterol Suppl; 2003; (239):69-72. PubMed ID: 14743886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy.
    van de Meeberg MM; Derikx LA; Sinnige HA; Nooijen P; Schipper DL; Nissen LH
    World J Gastroenterol; 2016 Dec; 22(47):10465-10470. PubMed ID: 28058028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiopurines are an independent risk factor for active tuberculosis in inflammatory bowel disease patients.
    Fortes FML; Rocha R; Santana GO
    World J Gastroenterol; 2023 Mar; 29(9):1536-1538. PubMed ID: 36998430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatosplenic T-cell lymphoma in patients receiving TNF-α inhibitor therapy: expanding the groups at risk.
    Parakkal D; Sifuentes H; Semer R; Ehrenpreis ED
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1150-6. PubMed ID: 21941193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update.
    Mackey AC; Green L; Leptak C; Avigan M
    J Pediatr Gastroenterol Nutr; 2009 Mar; 48(3):386-8. PubMed ID: 19274799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.